Conservative treatments of retinoblastoma (RETINO 2011)
1. -Multicentric non randomised, phase II study for the patients treated by chemoreduction
(VP16, carboplatin) followed by chemothermotherapy without laser treatment at day 8
2. -Multicentric non randomised, phase II study for the patients with bilateral very
asymmetric dis-ease (Group D eye on one of the eye) or unilateral presentation groups
B/C/D according to the age and vitreous seeding
3. - Multicentric non randomised, phase II study for the patients treated by 6 cycles of
three drugs regimen and local treatments for bilateral group D eyes or on the only eye.